Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 7

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 7
---
 be voted in person at the Annual Meeting only if you obtain legal proxy from the broker, trustee or other nominee that holds your shares giving you the right to vote the shares. Even if you plan to attend the Annual Meeting, we recommend that you also submit your proxy card or follow the voting directions described below. Q: How can I vote my shares without attending the Annual Meeting? A: Shareholder of record — If you are a shareholder of record, there are three ways to vote without attending the Annual Meeting: • Via the Internet — You may vote by proxy via the Internet by following the instructions provided in the proxy card. • By Telephone — You may vote by proxy by telephone by calling the toll-free number found on the proxy card. • By Mail — You may vote by proxy by filling out the proxy card and returning it in the envelope provided. Beneficial owners — If you are a beneficial owner holding shares through a bank, broker, trustee or other nominee, please refer to the information forwarded by your bank, broker, trustee or other nominee to see the voting options available to you. 3 TABLE OF CONTENTS Q: What proposals will be voted on at the Annual Meeting? A: At the Annual Meeting, shareholders will be asked to vote: (1) To elect the four Class II directors identified in this proxy statement to serve as Class II directors until the annual general meeting held in 2026 and until their successors are duly elected and qualified; (2) To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; (3) To vote on a non-binding advisory resolution regarding the compensation of our named executive officers; and (4) To transact such other business as may properly come before the Annual Meeting or any adjournment thereof. Q: What is the voting requirement to approve each of the proposals? A: Proposal One — An ordinary resolution, being a simple majority of the votes duly cast at the annual general meeting, is required for the election of each director. If the number of shares voted “FOR” a director nominee exceeds the number of votes cast “AGAINST,” the nominee will be elected as a director. You may vote “FOR,” “AGAINST” or “ABSTAIN” on each of the nominees for election as director. Abstentions and broker non-votes will not affect the outcome of Proposal One, other than counting towards the quorum of the meeting. Proposal Two — An ordinary resolution, being